1. Home
  2. LOAR vs GH Comparison

LOAR vs GH Comparison

Compare LOAR & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LOAR
  • GH
  • Stock Information
  • Founded
  • LOAR 2012
  • GH 2011
  • Country
  • LOAR United States
  • GH United States
  • Employees
  • LOAR N/A
  • GH N/A
  • Industry
  • LOAR
  • GH Medical Specialities
  • Sector
  • LOAR
  • GH Health Care
  • Exchange
  • LOAR NYSE
  • GH Nasdaq
  • Market Cap
  • LOAR 6.3B
  • GH 5.5B
  • IPO Year
  • LOAR 2024
  • GH 2018
  • Fundamental
  • Price
  • LOAR $96.76
  • GH $41.68
  • Analyst Decision
  • LOAR Strong Buy
  • GH Strong Buy
  • Analyst Count
  • LOAR 4
  • GH 21
  • Target Price
  • LOAR $84.00
  • GH $52.81
  • AVG Volume (30 Days)
  • LOAR 730.0K
  • GH 2.7M
  • Earning Date
  • LOAR 05-13-2025
  • GH 04-30-2025
  • Dividend Yield
  • LOAR N/A
  • GH N/A
  • EPS Growth
  • LOAR N/A
  • GH N/A
  • EPS
  • LOAR 0.24
  • GH N/A
  • Revenue
  • LOAR $402,819,000.00
  • GH $773,996,000.00
  • Revenue This Year
  • LOAR $24.82
  • GH $19.53
  • Revenue Next Year
  • LOAR $19.15
  • GH $21.92
  • P/E Ratio
  • LOAR $403.29
  • GH N/A
  • Revenue Growth
  • LOAR 26.88
  • GH 28.20
  • 52 Week Low
  • LOAR $45.13
  • GH $18.01
  • 52 Week High
  • LOAR $99.16
  • GH $52.92
  • Technical
  • Relative Strength Index (RSI)
  • LOAR N/A
  • GH 43.69
  • Support Level
  • LOAR N/A
  • GH $38.86
  • Resistance Level
  • LOAR N/A
  • GH $52.92
  • Average True Range (ATR)
  • LOAR 0.00
  • GH 2.99
  • MACD
  • LOAR 0.00
  • GH -0.74
  • Stochastic Oscillator
  • LOAR 0.00
  • GH 20.06

About LOAR LOAR HOLDINGS INC

Loar Holdings Inc in the design, manufacture, and sale of niche aerospace and defense components that are essential for today's aircraft and aerospace and defense systems. Its manufactured products includes auto throttles, lap-belt airbags, two- and three-point seat belts, water purification systems, fire barriers, polyimide washers and bushings, latches, hold-open and tie rods, temperature and fluid sensors and switches, carbon and metallic brake discs, fluid and pneumatic-based ice protection, RAM air components, sealing solutions and motion and actuation devices, among others. It operate across ten manufacturing facilities located in the United States, one manufacturing facility in Germany and one manufacturing facility in the United Kingdom (UK).

About GH Guardant Health Inc.

Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

Share on Social Networks: